These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31402456)

  • 1. Prediagnosis aspirin use, DNA methylation, and mortality after breast cancer: A population-based study.
    Wang T; McCullough LE; White AJ; Bradshaw PT; Xu X; Cho YH; Terry MB; Teitelbaum SL; Neugut AI; Santella RM; Chen J; Gammon MD
    Cancer; 2019 Nov; 125(21):3836-3844. PubMed ID: 31402456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes.
    McCullough LE; Chen J; Cho YH; Khankari NK; Bradshaw PT; White AJ; Teitelbaum SL; Terry MB; Neugut AI; Hibshoosh H; Santella RM; Gammon MD
    Breast Cancer Res; 2017 Feb; 19(1):19. PubMed ID: 28222775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation modifies the association between obesity and survival after breast cancer diagnosis.
    McCullough LE; Chen J; Cho YH; Khankari NK; Bradshaw PT; White AJ; Garbowski G; Teitelbaum SL; Terry MB; Neugut AI; Hibshoosh H; Santella RM; Gammon MD
    Breast Cancer Res Treat; 2016 Feb; 156(1):183-94. PubMed ID: 26945992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
    Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Inactivation of BRCA1 Through Promoter Hypermethylation and Its Clinical Importance in Triple-Negative Breast Cancer.
    Yamashita N; Tokunaga E; Kitao H; Hitchins M; Inoue Y; Tanaka K; Hisamatsu Y; Taketani K; Akiyoshi S; Okada S; Oda Y; Saeki H; Oki E; Maehara Y
    Clin Breast Cancer; 2015 Dec; 15(6):498-504. PubMed ID: 26195437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-diagnostic aspirin use and mortality after breast cancer.
    Wang T; Parada H; McClain KM; Bradshaw PT; Terry MB; Teitelbaum SL; Neugut AI; Gammon MD
    Cancer Causes Control; 2018 May; 29(4-5):417-425. PubMed ID: 29516320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene promoter methylation is associated with increased mortality among women with breast cancer.
    Xu X; Gammon MD; Zhang Y; Cho YH; Wetmur JG; Bradshaw PT; Garbowski G; Hibshoosh H; Teitelbaum SL; Neugut AI; Santella RM; Chen J
    Breast Cancer Res Treat; 2010 Jun; 121(3):685-92. PubMed ID: 19921426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1 promoter methylation is associated with increased mortality among women with breast cancer.
    Xu X; Gammon MD; Zhang Y; Bestor TH; Zeisel SH; Wetmur JG; Wallenstein S; Bradshaw PT; Garbowski G; Teitelbaum SL; Neugut AI; Santella RM; Chen J
    Breast Cancer Res Treat; 2009 May; 115(2):397-404. PubMed ID: 18521744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic relevance of promoter hypermethylation of multiple genes in breast cancer patients.
    Sharma G; Mirza S; Yang YH; Parshad R; Hazrah P; Datta Gupta S; Ralhan R
    Cell Oncol; 2009; 31(6):487-500. PubMed ID: 19940364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy.
    Xu Y; Diao L; Chen Y; Liu Y; Wang C; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Deng D; Narod SA; Xie Y
    Ann Oncol; 2013 Jun; 24(6):1498-505. PubMed ID: 23406733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproductive characteristics are associated with gene-specific promoter methylation status in breast cancer.
    McCullough LE; Collin LJ; Conway K; White AJ; Cho YH; Shantakumar S; Terry MB; Teitelbaum SL; Neugut AI; Santella RM; Chen J; Gammon MD
    BMC Cancer; 2019 Sep; 19(1):926. PubMed ID: 31533668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of BRCA1 promoter region is associated with unfavorable prognosis in women with early-stage breast cancer.
    Hsu NC; Huang YF; Yokoyama KK; Chu PY; Chen FM; Hou MF
    PLoS One; 2013; 8(2):e56256. PubMed ID: 23405268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia.
    Harahap WA; Sudji IR; Nindrea RD
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2643-2649. PubMed ID: 30256562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sources of polycyclic aromatic hydrocarbons are associated with gene-specific promoter methylation in women with breast cancer.
    White AJ; Chen J; Teitelbaum SL; McCullough LE; Xu X; Hee Cho Y; Conway K; Beyea J; Stellman SD; Steck SE; Mordukhovich I; Eng SM; Beth Terry M; Engel LS; Hatch M; Neugut AI; Hibshoosh H; Santella RM; Gammon MD
    Environ Res; 2016 Feb; 145():93-100. PubMed ID: 26671626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter Hypermethylation and Expression Changes of BRCA1 Gene in a Cohort of Sporadic Breast Cancer Cases among Pakistani Population.
    Arif T; Anwar N
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2395-2401. PubMed ID: 32856871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.
    Kehm RD; Hopper JL; John EM; Phillips KA; MacInnis RJ; Dite GS; Milne RL; Liao Y; Zeinomar N; Knight JA; Southey MC; Vahdat L; Kornhauser N; Cigler T; Chung WK; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; Daly MB; Terry MB
    Breast Cancer Res; 2019 Apr; 21(1):52. PubMed ID: 30999962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females.
    Al-Moghrabi N; Nofel A; Al-Yousef N; Madkhali S; Bin Amer SM; Alaiya A; Shinwari Z; Al-Tweigeri T; Karakas B; Tulbah A; Aboussekhra A
    BMC Cancer; 2014 Nov; 14():830. PubMed ID: 25403427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation.
    Iwamoto T; Yamamoto N; Taguchi T; Tamaki Y; Noguchi S
    Breast Cancer Res Treat; 2011 Aug; 129(1):69-77. PubMed ID: 20882403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of folate and other one-carbon related nutrients with hypermethylation status and expression of RARB, BRCA1, and RASSF1A genes in breast cancer patients.
    Pirouzpanah S; Taleban FA; Mehdipour P; Atri M
    J Mol Med (Berl); 2015 Aug; 93(8):917-34. PubMed ID: 25805039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of BRCA1 gene: implication for prognostic biomarker and therapeutic target in sporadic primary triple-negative breast cancer.
    Zhu X; Shan L; Wang F; Wang J; Wang F; Shen G; Liu X; Wang B; Yuan Y; Ying J; Yang H
    Breast Cancer Res Treat; 2015 Apr; 150(3):479-86. PubMed ID: 25783183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.